150 related articles for article (PubMed ID: 15571777)
21. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
[TBL] [Abstract][Full Text] [Related]
22. Label-free reading of microarray-based immunoassays with surface plasmon resonance imaging.
Kanda V; Kariuki JK; Harrison DJ; McDermott MT
Anal Chem; 2004 Dec; 76(24):7257-62. PubMed ID: 15595867
[TBL] [Abstract][Full Text] [Related]
23. Antibody-antigenic peptide interactions monitored by SPR and QCM-D. A model for SPR detection of IA-2 autoantibodies in human serum.
Ayela C; Roquet F; Valera L; Granier C; Nicu L; Pugnière M
Biosens Bioelectron; 2007 Jun; 22(12):3113-9. PubMed ID: 17349782
[TBL] [Abstract][Full Text] [Related]
24. Detection of insulin-antibody binding on a solid surface using imaging ellipsometry.
Bae YM; Oh BK; Lee W; Lee WH; Choi JW
Biosens Bioelectron; 2004 Nov; 20(4):895-902. PubMed ID: 15522607
[TBL] [Abstract][Full Text] [Related]
25. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology.
Jönsson U; Fägerstam L; Ivarsson B; Johnsson B; Karlsson R; Lundh K; Löfås S; Persson B; Roos H; Rönnberg I
Biotechniques; 1991 Nov; 11(5):620-7. PubMed ID: 1804254
[TBL] [Abstract][Full Text] [Related]
26. Detection of gastric carcinoma-associated antigen MG7-Ag in human sera using surface plasmon resonance sensor.
Fang X; Tie J; Xie Y; Li Q; Zhao Q; Fan D
Cancer Epidemiol; 2010 Oct; 34(5):648-51. PubMed ID: 20887942
[TBL] [Abstract][Full Text] [Related]
27. Comparison of surface plasmon resonance and capacitive immunosensors for cancer antigen 125 detection in human serum samples.
Suwansa-ard S; Kanatharana P; Asawatreratanakul P; Wongkittisuksa B; Limsakul C; Thavarungkul P
Biosens Bioelectron; 2009 Aug; 24(12):3436-41. PubMed ID: 19553100
[TBL] [Abstract][Full Text] [Related]
28. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
Nishikawa H; Sato E; Briones G; Chen LM; Matsuo M; Nagata Y; Ritter G; Jäger E; Nomura H; Kondo S; Tawara I; Kato T; Shiku H; Old LJ; Galán JE; Gnjatic S
J Clin Invest; 2006 Jul; 116(7):1946-54. PubMed ID: 16794737
[TBL] [Abstract][Full Text] [Related]
29. Label-free assessment of high-affinity antibody-antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry.
Rispens T; Te Velthuis H; Hemker P; Speijer H; Hermens W; Aarden L
J Immunol Methods; 2011 Feb; 365(1-2):50-7. PubMed ID: 21115013
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic device for immunoassays based on surface plasmon resonance imaging.
Luo Y; Yu F; Zare RN
Lab Chip; 2008 May; 8(5):694-700. PubMed ID: 18432338
[TBL] [Abstract][Full Text] [Related]
31. BIACORE J: a new platform for routine biomolecular interaction analysis.
Rich RL; Myszka DG
J Mol Recognit; 2001; 14(4):223-8. PubMed ID: 11500968
[TBL] [Abstract][Full Text] [Related]
32. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
33. Coupled waveguide-surface plasmon resonance biosensor with subwavelength grating.
Chien FC; Lin CY; Yih JN; Lee KL; Chang CW; Wei PK; Sun CC; Chen SJ
Biosens Bioelectron; 2007 May; 22(11):2737-42. PubMed ID: 17178218
[TBL] [Abstract][Full Text] [Related]
34. Label-free serodiagnosis on a grating coupler.
Nagel T; Ehrentreich-Förster E; Bier FF
Methods Mol Biol; 2009; 503():189-200. PubMed ID: 19151942
[TBL] [Abstract][Full Text] [Related]
35. A label-free immunoassay based upon localized surface plasmon resonance of gold nanorods.
Mayer KM; Lee S; Liao H; Rostro BC; Fuentes A; Scully PT; Nehl CL; Hafner JH
ACS Nano; 2008 Apr; 2(4):687-92. PubMed ID: 19206599
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors.
Bioley G; Guillaume P; Luescher I; Bhardwaj N; Mears G; Old L; Valmori D; Ayyoub M
J Immunother; 2009; 32(2):161-8. PubMed ID: 19238015
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a peptide ELISA for the detection of rituximab in serum.
Blasco H; Lalmanach G; Godat E; Maurel MC; Canepa S; Belghazi M; Paintaud G; Degenne D; Chatelut E; Cartron G; Le Guellec C
J Immunol Methods; 2007 Aug; 325(1-2):127-39. PubMed ID: 17651747
[TBL] [Abstract][Full Text] [Related]
38. Multiple label-free detection of antigen-antibody reaction using localized surface plasmon resonance-based core-shell structured nanoparticle layer nanochip.
Endo T; Kerman K; Nagatani N; Hiepa HM; Kim DK; Yonezawa Y; Nakano K; Tamiya E
Anal Chem; 2006 Sep; 78(18):6465-75. PubMed ID: 16970322
[TBL] [Abstract][Full Text] [Related]
39. Real-time detection of lymphocytes binding on an antibody chip using SPR imaging.
Suraniti E; Sollier E; Calemczuk R; Livache T; Marche PN; Villiers MB; Roupioz Y
Lab Chip; 2007 Sep; 7(9):1206-8. PubMed ID: 17713622
[TBL] [Abstract][Full Text] [Related]
40. Surface plasmon resonance-based trace detection of small molecules by competitive and signal enhancement immunoreaction.
Aizawa H; Tozuka M; Kurosawa S; Kobayashi K; Reddy SM; Higuchi M
Anal Chim Acta; 2007 May; 591(2):191-4. PubMed ID: 17481407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
